| M03BB52 |
M03BB52 chlormezanone, combinations excl. psycholeptics |
| M03BB53 |
M03BB53 chlorzoxazone, combinations excl. psycholeptics |
| M03BB72 |
M03BB72 chlormezanone, combinations with psycholeptics |
| M03BB73 |
M03BB73 chlorzoxazone, combinations with psycholeptics |
| M03BC |
M03BC Ethers, chemically close to antihistamines |
| M03BC01 |
M03BC01 orphenadrine (citrate) |
| M03BC51 |
M03BC51 orphenadrine, combinations |
| M03BX |
M03BX Other centrally acting agents |
| M03BX01 |
M03BX01 baclofen |
| M03BX02 |
M03BX02 tizanidine |
| M03BX03 |
M03BX03 pridinol |
| M03BX04 |
M03BX04 tolperisone |
| M03BX05 |
M03BX05 thiocolchicoside |
| M03BX06 |
M03BX06 mephenesin |
| M03BX07 |
M03BX07 tetrazepam |
| M03BX08 |
M03BX08 cyclobenzaprine |
| M03BX09 |
M03BX09 eperisone |
| M03BX30 |
M03BX30 fenyramidol |
| M03BX55 |
M03BX55 thiocolchicoside, combinations |
| M03C |
M03C Muscle relaxants, directly acting agents |
| M03CA |
M03CA Dantrolene And Derivatives |
| M03CA01 |
M03CA01 Dantrolene |
| M04 |
M04 Antigout preparations |
| M04A |
M04A Antigout preparations |
| M04AA |
M04AA Preparations inhibiting uric acid production |
| M04AA01 |
M04AA01 Allopurinol |
| M04AA02 |
M04AA02 tisopurine |
| M04AA03 |
M04AA03 febuxostat |
| M04AA51 |
M04AA51 allopurinol, combinations |
| M04AB |
M04AB Preparations increasing uric acid excretion |